[1]
Gök Sargın, Z. 2023. Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy. Turkish Journal of Gastroenterology. 34, 3 (Mar. 2023), 308–309. DOI:https://doi.org/10.5152/tjg.2023.23070.